Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study
Objectives To identify underlying subgroups with distinct symptom profiles, and to characterise and compare these subgroups across a range of demographic, clinical and psychosocial factors, within a heterogeneous group of patients with well-defined post-treatment Lyme disease (PTLD).Design A clinica...
Guardado en:
Autores principales: | Ting Yang, Alison W Rebman, John N Aucott |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d2c31bf8e28410e9b71b5ed92072c13 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients
por: Madeleine Morrissette, et al.
Publicado: (2020) -
Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease.
por: Mark W Eshoo, et al.
Publicado: (2012) -
Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease
por: Jerome Bouquet, et al.
Publicado: (2016) -
An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga A, et al.
Publicado: (2017) -
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.
por: Dana Pape-Zambito, et al.
Publicado: (2014)